Ochre Bio co-founders Quin Wills, chief scientific officer (left), and Jack O’Meara, CEO (right). Photo by Business Wire. A biotech startup developing RNA therapies for liver disease by running tests in live human livers has raised $30 million to identify a drug candidate to test in real live humans. Ochre Bio conducts its research with donor livers. These livers […]
